These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23806527)

  • 1. Histologic prognostic factors associated with chromosomal imbalances in a contemporary series of 89 clear cell renal cell carcinomas.
    Dagher J; Dugay F; Verhoest G; Cabillic F; Jaillard S; Henry C; Arlot-Bonnemains Y; Bensalah K; Oger E; Vigneau C; Rioux-Leclercq N; Belaud-Rotureau MA
    Hum Pathol; 2013 Oct; 44(10):2106-15. PubMed ID: 23806527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 9p deletions are an independent predictor of tumor progression following nephrectomy in patients with localized clear cell renal cell carcinoma.
    de Oliveira D; Dall'Oglio MF; Reis ST; Zerati M; Souza IC; Leite KR; Srougi M
    Urol Oncol; 2014 Jul; 32(5):601-6. PubMed ID: 24629495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
    Gronwald J; Störkel S; Holtgreve-Grez H; Hadaczek P; Brinkschmidt C; Jauch A; Lubinski J; Cremer T
    Cancer Res; 1997 Feb; 57(3):481-7. PubMed ID: 9012478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma.
    Fukatsu A; Tsuzuki T; Sassa N; Nishikimi T; Kimura T; Majima T; Yoshino Y; Hattori R; Gotoh M
    Am J Clin Pathol; 2013 Oct; 140(4):500-5. PubMed ID: 24045546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
    Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
    Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of pathologic factors to efficacy of sorafenib treatment in patients with metastatic clear cell renal cell carcinoma.
    Araki H; Tsuzuki T; Kimura T; Tanaka K; Yamada S; Sassa N; Yoshino Y; Hattori R; Gotoh M
    Am J Clin Pathol; 2015 Apr; 143(4):492-9. PubMed ID: 25780000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.
    Teng J; Gao Y; Chen M; Wang K; Cui X; Liu Y; Xu D
    Chin Med J (Engl); 2014; 127(9):1640-4. PubMed ID: 24791867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
    Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
    Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
    Nishikimi T; Tsuzuki T; Fujita T; Sassa N; Fukatsu A; Katsuno S; Yoshino Y; Hattori R; Gotoh M
    Pathol Int; 2011 Mar; 61(3):116-21. PubMed ID: 21355952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.
    Sperga M; Martinek P; Vanecek T; Grossmann P; Bauleth K; Perez-Montiel D; Alvarado-Cabrero I; Nevidovska K; Lietuvietis V; Hora M; Michal M; Petersson F; Kuroda N; Suster S; Branzovsky J; Hes O
    Virchows Arch; 2013 Oct; 463(4):563-73. PubMed ID: 23913167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
    Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
    J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.